These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23117210)

  • 1. Adaptation and validation of the Cambridge pulmonary hypertension outcome review for Sweden.
    Selimovic N; Rundqvist B; Kjörk E; Viriden J; Twiss J; McKenna SP
    Scand J Public Health; 2012 Dec; 40(8):777-83. PubMed ID: 23117210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire.
    Reis A; Twiss J; Vicente M; Gonçalves F; Carvalho L; Meireles J; Melo A; McKenna SP; Almeida L
    Health Qual Life Outcomes; 2016 Jul; 14(1):110. PubMed ID: 27460644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAPTATION AND VALIDATION OF THE CAMBRIDGE PULMONARY HYPERTENSION OUTCOME REVIEW (CAMPHOR) FOR CROATIA.
    Hećimović A; Heaney A; McKenna SP; Basara L; Jakopović M; Vukić Dugac A; Redžepi G; Rotim C; Samaržija M; Jokić-Begić N; Popović-Grle S
    Acta Clin Croat; 2019 Mar; 58(1):3-12. PubMed ID: 31363319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The German adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).
    Cima K; Twiss J; Speich R; McKenna SP; Grünig E; Kähler CM; Ehlken N; Treder U; Crawford SR; Huber LC; Ulrich S
    Health Qual Life Outcomes; 2012 Sep; 10():110. PubMed ID: 22971041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptation and Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for Use in Spain.
    Aguirre-Camacho A; Stepanous J; Blanco-Donoso LM; Moreno-Jiménez B; Wilburn J; González-Saiz L; McKenna SP
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):467-473. PubMed ID: 27989660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension.
    McKenna SP; Doughty N; Meads DM; Doward LC; Pepke-Zaba J
    Qual Life Res; 2006 Feb; 15(1):103-15. PubMed ID: 16411035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) into French-Canadian and English-Canadian.
    Coffin D; Duval K; Martel S; Granton J; Lefebvre MC; Meads DM; Twiss J; McKenna SP
    Can Respir J; 2008 Mar; 15(2):77-83. PubMed ID: 18354747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Polish adaptation of the CAMbridge Pulmonary Hypertension Outcome Review (CAMPHOR).
    Małaczynska-Rajpold K; Smukowska-Gorynia A; Heaney A; McKenna SP; Janus M; Araszkiewicz A; Jankiewicz S; Slawek-Szmyt S; Tomaszewska I; Mularek-Kubzdela T
    Cardiol J; 2020; 27(5):608-615. PubMed ID: 30338844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. United States validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).
    Gomberg-Maitland M; Thenappan T; Rizvi K; Chandra S; Meads DM; McKenna SP
    J Heart Lung Transplant; 2008 Jan; 27(1):124-30. PubMed ID: 18187098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Australian and New Zealand population.
    Ganderton L; Jenkins S; McKenna SP; Gain K; Fowler R; Twiss J; Gabbay E
    Respirology; 2011 Nov; 16(8):1235-40. PubMed ID: 21810146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands.
    Wapenaar M; Twiss J; Wagenaar M; Seijkens P; van den Toorn L; Stepanous J; Heaney A; van den Bosch A; Boomars KA
    Neth Heart J; 2016 Jun; 24(6):417-424. PubMed ID: 27197970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-cultural adaptation of the Cambridge Pulmonary Hypertension Outcome Review for use in patients with pulmonary hypertension in Colombia.
    Villaquirán C; Moreno S; Dueñas R; Acuña P; Lutz JR; Wilburn J; Heaney A
    J Bras Pneumol; 2019 Jul; 45(6):e20180332. PubMed ID: 31365733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rheumatoid Arthritis Quality of Life (RAQoL) for Sweden: adaptation and validation.
    Hedin PJ; McKenna SP; Meads DM
    Scand J Rheumatol; 2006; 35(2):117-23. PubMed ID: 16641045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptation and validation of the quality of life assessment of the Cambridge pulmonary hypertension outcome review (CAMPHOR) for Brazil.
    Corrêa RA; Pereira MC; Bizzi MF; de Oliveira RWR; Rezende CF; de Oliveira BCMT; Heaney A; McKenna SP; Ribeiro-Oliveira A
    J Patient Rep Outcomes; 2020 Jun; 4(1):43. PubMed ID: 32504261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Swedish version of the Clinical Outcomes in Routine Evaluation Outcome Measure (CORE-OM).
    Elfström ML; Evans C; Lundgren J; Johansson B; Hakeberg M; Carlsson SG
    Clin Psychol Psychother; 2013; 20(5):447-55. PubMed ID: 22438100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation and validation of restless leg syndrome quality of life questionnaire in Hindi language.
    Vishwakarma K; Lahan V; Gupta R; Goel D; Dhasmana DC; Sharma T; Kalra J
    Neurol India; 2012; 60(5):476-80. PubMed ID: 23135023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension.
    Twiss J; McKenna S; Ganderton L; Jenkins S; Ben-L'amri M; Gain K; Fowler R; Gabbay E
    BMC Pulm Med; 2013 Jul; 13():45. PubMed ID: 23844640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Life in Depression Scale (QLDS): adaptation and evaluation of the psychometric properties of the Norwegian version.
    Berle JØ; McKenna SP
    Nord J Psychiatry; 2004; 58(6):439-46. PubMed ID: 16195087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of the Dry Eye-Related Quality-of-Life Score questionnaire.
    Sakane Y; Yamaguchi M; Yokoi N; Uchino M; Dogru M; Oishi T; Ohashi Y; Ohashi Y
    JAMA Ophthalmol; 2013 Oct; 131(10):1331-8. PubMed ID: 23949096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the French version of the arthritis impact measurement scales 2 and comparison with the french version of the Nottingham Health Profile. "Quality of Life in Rheumatology" Task Force.
    Pouchot J; Guillemin F; Coste J; Brégeon C; Sany J
    Rev Rhum Engl Ed; 1996 Jun; 63(6):389-404. PubMed ID: 8817749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.